Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck buys British maker of biotech medicines
Yahoo/AP
Thursday, December 17, 2009 - 1:34pm
tags:
Merck, M&A, Avecia
Durect: Pain anesthesia shows positive results
Yahoo/AP
Thursday, December 17, 2009 - 1:33pm
tags:
Durect Corporation, clinical trials, Posidur
Arena Pharmaceuticals shares fall on Jefferies analyst 'Hold' rating, view on obesity drug
Yahoo/AP
Thursday, December 17, 2009 - 1:32pm
tags:
obesity, Arena Pharmaceuticals, lorcaserin
Sanofi Sales Rep Sues For Overtime Pay
Pharmalot
Thursday, December 17, 2009 - 1:31pm
tags:
overtime lawsuits, drug reps
Merck and J&J Land Deals; Biogen Idec, Not So Much
WSJ Online
Thursday, December 17, 2009 - 1:28pm
tags:
Biogen Idec, Merck, JNJ, Facet Biotech, M&A
GSK Plunges Into Patches, a Technology With a Troubled History
BNET Pharma
Thursday, December 17, 2009 - 9:31am
tags:
GSK, Intercell, vaccines, vaccine patches, M&A
Novelos CEO: Very Bullish About Upcoming Pivotal Phase III Results
Seeking Alpha
Thursday, December 17, 2009 - 9:30am
tags:
Novelos Therapeutics, clinical trials, lung cancer
Cytori Therapeutics: Don't Buy In to the Momentum
Seeking Alpha
Thursday, December 17, 2009 - 9:29am
tags:
Cytori
Matthew Herper On The New Genetic Revolution
Forbes
Thursday, December 17, 2009 - 9:22am
tags:
genetics, genetic medicine
Talecris Bounces Off IPO Price: Strong Growth Potential
Seeking Alpha
Thursday, December 17, 2009 - 9:21am
tags:
IPOs, Talecris
A Certificate Program For Pharma Sales Reps Is On Its Way
Pharmalot
Thursday, December 17, 2009 - 9:18am
tags:
drug reps, Medical Representatives Certification Commission
Siga Technologies: Is the Volatility Over?
Seeking Alpha
Thursday, December 17, 2009 - 9:17am
tags:
SIGA technologies
Ipsen, Roche’s Taspoglutide Matches Sanofi’s Lantus
Bloomberg
Thursday, December 17, 2009 - 8:57am
tags:
Lantus, diabetes, Ipsen, Roche, taspoglutide
Panel Rejects Early Use of Tarceva
WSJ Online
Wednesday, December 16, 2009 - 10:10pm
tags:
Tarceva, OSI Pharmaceuticals, FDA, lung cancer, Roche, Genentech
Efficacy of Roche's Flu Drug Tamiflu In Doubt
BNET Pharma
Wednesday, December 16, 2009 - 5:51pm
tags:
Roche, Flu, Tamiflu
Better Buy: Johnson & Johnson or Bristol-Myers Squibb?
Motley Fool
Wednesday, December 16, 2009 - 5:50pm
tags:
JNJ, Bristol-Myers Squibb
Amylin Impresses in Head-to-Head
Yahoo/Zacks.com
Wednesday, December 16, 2009 - 5:48pm
tags:
Johnson & Johnson's Ethicon unit paying $785 million for sinus surgery device maker Acclarent
Yahoo/AP
Wednesday, December 16, 2009 - 5:48pm
tags:
JNJ, M&A, Acclarent, medical devices
Gilead's Phase 3 Train Wreck
Motley Fool
Wednesday, December 16, 2009 - 3:34pm
tags:
Gilead Sciences, darusentan
Drug stocks rise; Achillion, Sanofi in play
Marketwatch
Wednesday, December 16, 2009 - 11:34am
tags:
drug stocks, Achillion, Sanofi

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.